NCT04466748View on ClinicalTrials.gov

A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 8, 2015

Primary Completion Date

December 29, 2015

Study Completion Date

December 29, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

Anaprazole Sodium enteric-coated tablet

Multiple ascendinng dose, anaprazole 20mg QD(20mg QD group), 40mg QD(40mg QD group), 20mg Bid(20mg Bid group) , 6 days, fasting oral administration.

DRUG

Placebo

Multiple dose, 1 tablet QD (20mg QD and 40mg QD group), 1 tablet Bid (20mg Bid group), 6 days, fasting oral administration.

All Listed Sponsors
lead

Sihuan Pharmaceutical Holdings Group Ltd.

INDUSTRY

NCT04466748 - A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects | Biotech Hunter | Biotech Hunter